TY - JOUR
T1 - Metastatic colon cancer, version 3.2013
T2 - Featured updates to the NCCN guidelines
AU - Benson, Al B.
AU - Bekaii-Saab, Tanios
AU - Chan, Emily
AU - Chen, Yi Jen
AU - Choti, Michael A.
AU - Cooper, Harry S.
AU - Engstrom, Paul F.
AU - Enzinger, Peter C.
AU - Fakih, Marwan G.
AU - Fenton, Moon J.
AU - Fuchs, Charles S.
AU - Grem, Jean L.
AU - Hunt, Steven
AU - Kamel, Ahmed
AU - Leong, Lucille A.
AU - Lin, Edward
AU - May, Kilian Salerno
AU - Mulcahy, Mary F.
AU - Murphy, Kate
AU - Rohren, Eric
AU - Ryan, David P.
AU - Saltz, Leonard
AU - Sharma, Sunil
AU - Shibata, David
AU - Skibber, John M.
AU - Jr, William Small
AU - Sofocleous, Constantinos T.
AU - Venook, Alan P.
AU - Willett, Christopher G.
AU - Gregory, Kristina M.
AU - Freedman-Cass, Deborah A.
PY - 2013/2/1
Y1 - 2013/2/1
N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.
AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy.
KW - Colonic Neoplasms/pathology
KW - Humans
KW - Medical Oncology/education
KW - Neoplasm Metastasis
KW - Practice Guidelines as Topic
UR - http://www.scopus.com/inward/record.url?scp=84874641687&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000314795200005&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.6004/jnccn.2013.0022
DO - 10.6004/jnccn.2013.0022
M3 - Article
C2 - 23411381
SN - 1540-1405
VL - 11
SP - 141
EP - 152
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 2
ER -
